Reviewed by Anuj K. Patel, MD, Clinical Director of the Center for Esophageal and Gastric Cancer at the Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School in ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

In resectable gastric and gastroesophageal junction cancer, adding durvalumab to perioperative chemotherapy improved event-free survival and pathological complete response, with no major increase in ...

Stomach cancer, or gastric cancer, is the third leading cause of cancer deaths worldwide, largely because most individuals are not diagnosed until after the cancer has progressed to a late stage. The ...